Live Feeds
● LIVE Updated 1h ago · 14 sources tracked

Ozempic and Wegovy may strengthen bones in Type 2 diabetes patients, study finds

Recent research indicates that Ozempic and Wegovy may strengthen bones and lower the risk of fractures for patients with Type 2 diabetes. These drugs contain the active ingredient semaglutide. Data presented at ENDO 2026 also links GLP-1s to increased brown fat activity.

RSS Source map (14)

What changed

New study data suggests semaglutide provides bone health benefits beyond weight loss.

Live updates

  1. Semaglutide May Reduce Bone Fracture Risk in Type 2 Diabetes Patients

    Recent research indicates that Ozempic and Wegovy may strengthen bones and lower the risk of fractures for patients with Type 2 diabetes. These drugs contain the active ingredient semaglutide. Data presented at ENDO 2026 also links GLP-1s to increased brown fat activity.

    What's confirmed:

    • Ozempic and Wegovy contain the active ingredient semaglutide.
    • Research suggests semaglutide may strengthen bones in patients with Type 2 diabetes.
    • Type 2 diabetes patients using Ozempic and Wegovy were 15% less likely to suffer bone fractures than those using other weight-loss drugs.

    Still unconfirmed:

    • GLP-1s are linked to increased brown fat activity and one concerning trend according to ENDO 2026 data.
    • Weight-loss drugs like Ozempic can act as antidepressants due to changes in the gut microbiome.
    confidence 90%